Objectives Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin condition with no approved targeted treatments. Afimetoran – a first-in-class, once daily oral, selective, equipotent, ...

Objective SLE is prevalent among women of reproductive age, increasing the risk of adverse pregnancy outcomes (APOs). However, the correlation between the onset time of SLE and APOs remains unclear.

Objectives Systemic lupus erythematosus (SLE) is a chronic, immune-mediated disease that can affect multiple organ systems, causing debilitating symptoms, organ damage and impaired quality of life.

Objectives To describe treatment patterns and clinical outcomes of belimumab therapy in real-world patients with SLE, including clinical and laboratory disease activity measures, over a one-year ...

Objective To develop a Register-Based Organ Damage Index (RBODI) in SLE, and evaluate its accuracy in estimating Systemic Lupus International Collaborating Clinics/American College of Rheumatology ...

Objectives This study aimed to derive and validate a cut-off for severe disease activity (SDA) using the SLE Disease Activity Score (SLE-DAS) and compare its accuracy and impact on health-related ...

1 Rheumatology Unit, Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy 2 Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, ...

Objectives Flares may still occur after remission, affecting organ damage accrual and survival expectancy. Therefore, identifying predictors of these flares is clinically relevant, particularly in ...